Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) today provided an update on the Company’s business and announced financial results for the fourth quarter and year ended December 31, 2014.
Financial Highlights
•Fourth quarter net sales of $53.8 million and adjusted EBITDA of $22.9 million reflect record quarterly results
Help employers find you! Check out all the jobs and post your resume.
